Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aveo Pharmaceuticals (NQ: AVEO )

8.180 USD +0.030 (+0.37%)
Official Closing Price Updated: 7:22 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 851,200
Open 8.120
Bid (Size) 7.650 (1)
Ask (Size) 8.400 (5)
Prev. Close 8.150
Today's Range 7.410 - 8.240
52wk Range 2.230 - 10.71
Shares Outstanding 118,867,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AVEO Oncology to Present at the H.C. Wainwright Global Life Sciences Conference
AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will present at the H.C. Wainwright Global Life Sciences Conference, being held... 
From Business Wire News Releases
AVEO Oncology Announces Participation at the 2021 SVB Leerink Global Healthcare Conference
AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will participate in a fireside chat at the 2021 SVB Leerink Global Healthcare Conference... 
From Business Wire News Releases

Performance

YTD
+37.02%
+37.02%
1 Month
-8.60%
-8.60%
3 Month
+59.14%
+59.14%
6 Month
+56.11%
+56.11%
1 Year
+93.38%
+93.38%

More News

Read More
AVEO Oncology Announces Presentation of Key Subgroup and Quality of Life Analyses from the Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma
From Business Wire News Releases
AVEO Oncology Announces Commitment for an Incremental $10 Million Loan in Addition to Current Tranched, $35 Million Debt Facility with Hercules Capital
From Business Wire News Releases
AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA®) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma
From Business Wire News Releases
AVEO Oncology Highlights Recent Progress and 2021 Outlook
From Business Wire News Releases
AVEO Oncology Announces Participation at Two Upcoming Investor Conferences
From Business Wire News Releases
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags DFFN Market News NVAX
From Benzinga
AVEO Oncology Announces Webcast of Presentation at the 39th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
AVEO Oncology to Present at the Stifel 2020 Virtual Healthcare Conference
From Business Wire News Releases
AVEO Oncology Reports Third Quarter 2020 Financial Results and Provides Business Update
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.